Skip to main content
TipRanks
Go Ultimate75% OFF

Seelos Therapeutics (SEELQ) Ownership - Who Owns Seelos Therapeutics?

1,199 Followers

Seelos Therapeutics (SEELQ) Ownership Overview

  • 0.85% Mutual Funds
  • 1.51% Other Institutional Investors
  • 97.64% Public Companies and Individual Investors

The ownership structure of Seelos Therapeutics (SEELQ) stock is a mix of institutional, retail, and individual investors. Approximately 2.36% of the company’s stock is owned by Institutional Investors, and 97.64% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Recent Insider Trading Activity
DateNameActivityValue

Recent Hedge Fund Trading Activity

Recent Hedge Fund Trading Activity
DateFirmActivityValue

Top Shareholders

SEELQ top shareholders
Holder# of SharesType% HoldingValue
Victory Portfolios Iii11,646Institution0.85%―

Top Mutual Fund Holders

SEELQ top mutual fund holders
Holder# of SharesType% HoldingValue
Victory Portfolios Iii11,646Institution0.85%―

FAQ

What percentage of Seelos Therapeutics (SEELQ) stock is held by institutional investors?
According to the latest TipRanks data, approximately 2.36% of Seelos Therapeutics (SEELQ) stock is held by institutional investors: 0.85% by mutual funds and 1.51% by other institutional investors.
What percentage of Seelos Therapeutics (SEELQ) stock is held by retail investors?
According to the latest TipRanks data, approximately 97.64% of Seelos Therapeutics (SEELQ) stock is held by public companies and individual investors.
Who owns the most shares of Seelos Therapeutics (SEELQ)?
Victory Portfolios III owns the most shares of Seelos Therapeutics (SEELQ).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.